Madrigal Has A Slow, Steady Launch Planned For Rezdiffra

Drug pricing
Madrigal said it tried to balance value and access in pricing its MASH drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip